Seminars in Oncology
Volume 30, Issue 2 , Pages 121-126, April 2003

Treatment recommendations in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia☆☆☆

Mayo Clinic, Rochester, MN; M.D. Anderson Cancer Center, Houston, TX; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA; Weill Medical College of Cornell University, New York, NY; Greenbaum Cancer Center and University of Maryland, Baltimore, MD; and Washington University School of Medicine, St Louis, MO.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Waldenstrom's Macroglobulinemia Program, Dana Farber Cancer Institute, Harvard Medical School, LG100, 44 Binney St, Boston, MA 02115. Email: wmp@dfci.harvard.edu.

☆☆ 0093/7754/03/3002-0004$30.00/0

PII: S0093-7754(03)70061-X

doi:10.1053/sonc.2003.50039

Seminars in Oncology
Volume 30, Issue 2 , Pages 121-126, April 2003

Article Tools